Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus Infection

NCT00004644 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

Herpes Simplex

Interventions

DRUG: acyclovir

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]